Mifepristone oral dosage forms for use in cervical ripening and labor induction

摘要

At least 37 weeks of gestation, we provide a new dose of mifepristone oral dosage for use in uterine cervical ripening and labor induction in pregnant women with Bishop scores ranging from 0 to 6.Solution: a mifepristone oral formulation comprising mifepristone, which is selected from the group consisting of 75 mg, 150 mg or 300 mg, is further administered to the pregnant woman 24 hours ± 6 hours or 48 hours ± 6 hours after the initial dose.No selection